Pharma Mirror Magazine

Olympus EU-ME3 Ultrasound Processor, Delivers Higher Resolution Images for Endoscopic Ultrasound

October 13, 2022

TOKYO / HAMBURG, Olympus Corporation (Olympus), a global medtech company committed to making lives healthier, safer and more fulfilling, has announced

Pharmaceutical News

Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022

October 5, 2022

INCHEON, South Korea, Samsung Biologics (KRX: 207940.KS), a world-leading contract development and manufacturing organization (CDMO), is launching its new proprietary development

Pharmaceutical News

New resources from FIP aim to support pharmacists in providing services for people with chronic respiratory diseases

October 1, 2022

The Hague, Support for pharmacists to provide services to people with chronic respiratory diseases — namely asthma and chronic obstructive

Pharmaceutical News

Emmes Acquires Clinical Edge, Company’s Fifth Acquisition Deepens Ophthalmology Credentials and Enhances Global Reach

October 1, 2022

ROCKVILLE, Md., Sept. 28, 2022 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and

Pharmaceutical News

Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc

October 1, 2022

Nanjing (China) and Barcelona (Spain), a global biopharmaceutical company focused on skin health, and Simcere Pharmaceutical Group（2096.HK), an innovation and R&D-driven pharmaceutical

Pharmaceutical News

Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022

September 16, 2022

REHOVOT, Israel & WILMINGTON Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule

MORE NEWS

Olympus EU-ME3 Ultrasound Processor, Delivers Higher Resolution Images for Endoscopic Ultrasound

Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022

New resources from FIP aim to support pharmacists in providing services for people with chronic respiratory diseases

Emmes Acquires Clinical Edge, Company’s Fifth Acquisition Deepens Ophthalmology Credentials and Enhances Global Reach

Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc

Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022